HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Belagenpumatucel-L for the treatment of non-small cell lung cancer.

AbstractINTRODUCTION:
Immunotherapy has become a promising approach for the treatment of NSCLC. In order to stimulate the host immune system against tumour antigens, several cancer vaccines have been generated and evaluated. Belagenpumatucel-L is a whole tumour cell vaccine expressing the antisense strand of the TGF-β2 gene.
AREAS COVERED:
The purpose of this article is to review the most relevant findings of clinical trials testing belagenpumatucel-L in advanced NSCLC patients.
EXPERT OPINION:
Although the Phase III trial investigating belagenpumatucel-L in stage III/IV patients did not meet its primary end point, a survival benefit was observed in several subgroups of patients. Further studies are needed in order to select patients who may benefit from this vaccine.
AuthorsErika Rijavec, Federica Biello, Carlo Genova, Giulia Barletta, Claudia Maggioni, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Irene Vanni, Angela Alama, Sabrina Beltramini, Maria Attilia Grassi, Francesco Boccardo, Francesco Grossi
JournalExpert opinion on biological therapy (Expert Opin Biol Ther) Vol. 15 Issue 9 Pg. 1371-9 ( 2015) ISSN: 1744-7682 [Electronic] England
PMID26211534 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, Neoplasm
  • Cancer Vaccines
  • Transforming Growth Factor beta2
  • belagenpumatucel L
Topics
  • Antigens, Neoplasm (immunology)
  • Cancer Vaccines (immunology, therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (immunology, pathology, therapy)
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy
  • Lung Neoplasms (immunology, pathology, therapy)
  • Transforming Growth Factor beta2 (antagonists & inhibitors, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: